Short answer
Privia Health Group, Inc. (PRVA) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $657M (up 13.2% year over year) with net income of $13M.
Q3 2026 key financials · XBRL
- Revenue
- $657M
- +13.2% YoY · +3.8% QoQ
- Net income
- $13M
- +96.6% YoY · +49.1% QoQ
- Operating margin
- 3.1%
- EPS (diluted)
- $0.10
- +66.7% YoY · +42.9% QoQ
Source: XBRL data from the Privia Health Group, Inc. (PRVA) Q3 2026 10-Q on SEC EDGAR. USD.
Privia Health Group, Inc. Q3 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $657.0M, up 13.2% YoY from $580.4M, driven by FFS patient care growth
- Care Margin 21.0% vs 21.6% YoY, while Adjusted EBITDA Margin 29.4% vs 30.5%
- Best line FFS patient care: $433.1M, up 22.8%; weakest shared savings: $68.8M, down 13.9%
- Cash $446.3M; operating cash flow turned negative at $19.4M vs $35.9M provided YoY
- Near-term liquidity adequate; headwind from shared-savings timing and settlements
Risk Factors
- No material changes to risk factors disclosed in the latest Annual Report
- Key carried-forward risks not specified in the quarterly filing
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Privia Health Group, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.